Bausch Health Companies (BHC) Finished Goods (2012 - 2018)

Bausch Health Companies has disclosed Finished Goods across 7 years of filings, most recently posting $564.0 million for Q4 2018.

• Finished Goods for Q4 2018 came in at $564.0 million, down 9.9% year-over-year; the trailing twelve-month figure through Dec 2018 was $564.0 million (down 9.9% YoY), and the FY2018 annual result was $564.0 million, down 9.9% from the prior year.
• Finished Goods came in at $564.0 million for Q4 2018 at Bausch Health Companies, down from $584.0 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $843.0 million in Q2 2015 to a low of $564.0 million in Q4 2018.
• The 5-year median for Finished Goods is $618.0 million (2018), against an average of $658.1 million.
• Across the five-year window, Finished Goods jumped 34.96% in 2015 and declined 16.56% in 2016, its largest moves.
• Bausch Health Companies' Finished Goods stood at $603.9 million in 2014, then surged by 34.96% to $815.0 million in 2015, then decreased by 16.56% to $680.0 million in 2016, then slipped by 7.94% to $626.0 million in 2017, then slipped by 9.9% to $564.0 million in 2018.
• The last three Finished Goods figures came in at $564.0 million (Q4 2018), $584.0 million (Q3 2018), and $589.0 million (Q2 2018), per Business Quant data.